ZNF611
Zinc finger protein 611
Also known as: MGC5384, ZN611_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N823
- Gene
- ZNF611
- Ensembl
- ENSG00000213020
- Chromosome
- 19
- Canonical length
- 705 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
705 residues, UniProt reviewed canonical sequence.
>Q8N823|ZNF611
1 MLREEAAQKR KGKEPGMALP QGRLTFRDVA IEFSLAEWKC LNPSQRALYR EVMLENYRNL
61 EAVDISSKCM MKEVLSTGQG NTEVIHTGTL QRHESHHIGD FCFQEIEKEI HDIEFQCQED
121 ERNGLEAPMT KIKKLTGSTD QHDHRHAGNK PIKDQLGSSF YSHLPELHIF QIKGEIGNQL
181 EKSTNDAPSV STFQRISCRP QTQISNNYGN NPLNSSLLPQ KQEVHMREKS FQCNKSGKAF
241 NCSSLLRKHQ IPHLGDKQYK CDVCGKLFNH EQYLACHDRC HTVEKPYKCK ECGKTFSQES
301 SLTCHRRLHT GVKRYNCNEC GKIFGQNSAL LIDKAIDTGE NPYKCNECDK AFNQQSQLSH
361 HRIHTGEKPY KCEECDKVFS RKSTIETHKR IHTGEKPYRC KVCDTAFTWH SQLARHRRIH
421 TAKKTYKCNE CGKTFSHKSS LVCHHRLHGG EKSYKCKVCD KAFVWSSQLA KHTRIDCGEK
481 PYKCNECGKT FGQNSDLLIH KSIHTGEQPY KCDECEKVFS RKSSLETHKI GHTGEKPYKC
541 KVCDKAFACH SYLAKHTRIH SGEKPYKCNE CSKTFSHRSY LVCHHRVHSG EKPYKCNECS
601 KTFSRRSSLH CHRRLHSGEK PYKCNECGNT FRHCSSLIYH RRLHTGEKSY KCTICDKAFV
661 RNSLLSRHTR IHTAEKPYKC NECGKAFNQQ SHLSRHHRIH TGEKPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF611 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 6.5 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 6.5 nTPM
- seminal vesicle: 4.1 nTPM
- thymus: 4.1 nTPM
- pancreas: 4 nTPM
- placenta: 4 nTPM
- retina: 3.9 nTPM
Single-cell type
- ocular epithelial cells: 181 nCPM
- granulosa cells: 150 nCPM
- endometrial glandular cells: 113 nCPM
- proximal tubule cells: 111 nCPM
- endometrial luminal cells: 109 nCPM
- loop of henle epithelial cells: 95 nCPM
Immune cell
- neutrophil: 9.7 nTPM
- eosinophil: 8.9 nTPM
- basophil: 7.3 nTPM
- MAIT T-cell: 6.1 nTPM
- gdT-cell: 5.4 nTPM
- memory CD8 T-cell: 4.8 nTPM
Brain region
- white matter: 15 nTPM
- cerebellum: 13 nTPM
- pons: 12 nTPM
- basal ganglia: 12 nTPM
- medulla oblongata: 11 nTPM
- cerebral cortex: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.51
- gnomAD pLI
- 0.07
- gnomAD missense Z
- -1.51
- DepMap mean gene effect
- 0.29
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF611 as an antibody target. Whether an autoantibody or antibody against ZNF611 could matter depends on whether native ZNF611 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF611 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF611 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...